Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment. (Q51574846)

7 April 2018

title

Enhanced oxidizability of ubiquinol and alpha-tocopherol during lovastatin treatment. (English)

1 reference

7 April 2018

author name string

Palomäki A

series ordinal

1

1 reference

7 April 2018

Malminiemi K

series ordinal

2

1 reference

7 April 2018

Metsä-Ketelä T

series ordinal

3

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

7 April 2018

published in

FEBS Letters

1 reference

7 April 2018

volume

410

1 reference

7 April 2018

issue

2-3

1 reference

7 April 2018

page(s)

254-258

1 reference

7 April 2018

Regulation of the mevalonate pathway

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Distribution and redox state of ubiquinones in rat and human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Succinate-ubiquinone reductase linked recycling of α-tocopherol in reconstituted systems and mitochondria: Requirement for reduced ubiquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Interaction of nitrogen dioxide with human plasma. Antioxidant depletion and oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Low density lipoprotein is saturable by pro-oxidant copper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Determination of total protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Continuous monitoring of in vitro oxidation of human low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

A new micromethod for the colorimetric determination of inorganic phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

Membrane damage due to lipid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2897%2900609-1

10.1016/S0014-5793(97)00609-1

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

9237640

1 reference

7 April 2018